Publications
Cytoreductive Surgery With or Without HIPEC After Neoadjuvant Chemotherapy in Ovarian Cancer: A Phase 3 Clinical Trial
Cascales Campos Pedro Antonio, MD, PHD, Gonzalez Gil Alida, MD, PHD, Gil Gomez Elena, MD, PH1,Gonzalez Sanchez Rocio, PHD, Martınez Garcia Jeronimo, MD, PHD, Alonso Romero Jose Luis, MD, PHD, Nieto Diaz Anibal, MD, PHD, Barcelo Valcarcel Francisco, MD, PHD, Gomez Ruiz Alvaro Jesus, MD, PHD,Ramirez Romero Pablo, MD, PHD, and Gil Martinez Jose, MD, PHD
Read AbstractEvaluation of Cytoreductive Surgery With or Without Hyperthermic Intraperitoneal Chemotherapy for Stage III Epithelial Ovarian Cancer
Ziying Lei, MD; Yue Wang, MD; Jiahong Wang, MD; Ke Wang, MD; Jun Tian, MD; Ying Zhao, MD; Lipai Chen, MD; Jin Wang, MD; Jiali Luo, PhD; Manman Jia, MD;Hongsheng Tang, MD; Qingjun He, MD; Quanxing Liao, MD; Xiansheng Yang, MD; Tianpei Guan, MD; Li Wang, MD; Shuzhong Cui, MD, PhD;
Read AbstractThe prognosis impact of hyperthermic intraperitoneal chemotherapy (HIPEC) plus cytoreductive surgery (CRS) in advanced ovarian cancer: the meta-analysis
Guyu Zhang, Yimin Zhu, Chongdong Liu, Guangming Chao, Ran Cui and Zhenyu Zhang
Read AbstractSelection of patients with ovarian cancer who may show survival benefit from hyperthermic intraperitoneal chemotherapy: a systematic review and meta-analysis
Se Ik Kim, MD, Jaehyun Cho, MD, Eun Ji Lee, MD, Sunwoo Park, BS, Soo Jin Park, MDa,Aeran Seol, MD, Nara Lee, MD, Ga Won Yim, MD, PhD, Maria Lee, MD, PhD, Whasun Lim, PhD,Gwonhwa Song, PhD, Suk Joon Chang, MD, PhD, Jae Won Kim, MD, PhD, Hee Seung Kim, MD, PhD
Read AbstractCost-effectiveness of hyperthermic intraperitoneal chemotherapy (HIPEC) at interval debulking of epithelial ovarian cancer following neoadjuvant chemotherapy
Stephanie L.Lima, Laura J.Havrilesky, Ashraf S.Habib, Angeles Alvarez Secord
Read AbstractCost Effectiveness of Interval Cytoreductive Surgery With Hyperthermic Intraperitoneal Chemotherapy in Stage III Ovarian Cancer on the Basis of a Randomized Phase III Trial
Simone N. Koole, MD; Christiaan van Lieshout, MSc; Willemien J. van Driel, PhD, MD; Evi van Schagen, MSc;Karolina Sikorska, PhD; Jacobien M. Kieffer, PhD; Jules H. Schagen van Leeuwen, MD, PhD; Henk W.R. Schreuder, MD, PhD;Ralph H. Hermans, MD, PhD; Ignace H. de Hingh, MD, PhD; Jacobus van der Velden, PhD, MD; Henriette J. Arts, MD, PhD;Leon F.A.G. Massuger, MD, PhD; Arend G. Aalbers, MD; Victor J. Verwaal, MD, PhD; Koen K. Van de Vijver, MD, PhD;Neil K. Aaronson, PhD; Harm van Tinteren, PhD; Gabe S. Sonke, MD, PhD; Wim H. van Harten, MD, PhD;andValesca P. Ret`el, PhD
Read AbstractHyperthermic Intraperitoneal Chemotherapy in Ovarian Cancer
W.J. van Driel, S.N. Koole, K. Sikorska, J.H. Schagen van Leeuwen, H.W.R. Schreuder, R.H.M. Hermans, I.H.J.T. de Hingh, J. van der Velden, H.J. Arts, L.F.A.G. Massuger, A.G.J. Aalbers, V.J. Verwaal, J.M. Kieffer, K.K. Van de Vijver, H. van Tinteren, N.K. Aaronson, and G.S. Sonke
Read AbstractCytoreductive Surgery and HIPEC in Recurrent Epithelial Ovarian Cancer: A Prospective Randomized Phase III Study
J. Spiliotis, MD, PhD, E. Halkia, MD, PhD, E. Lianos, MD, N. Kalantzi, MD, A. Grivas, MD, E. Efstathiou, MD, and S. Giassas, MD
Read AbstractIntraperitoneal chemotherapy in ovarian cancer: a review of tolerance and efficacy
Daniel L Chan, David L Morris, Archana Rao, Terence C Chua
Read AbstractCytoreductive Surgery and Hyperthermic Intraperitoneal Chemotherapy (HIPEC) for Persistent and Recurrent Advanced Ovarian Carcinoma: A Multicenter, Prospective Study of 246 Patients
N. Bakrin, MD, E. Cotte, MD, F. Golfier MD, PhD, F. N. Gilly, MD, PhD, G. Freyer, MD, PhD, W. Helm, MD,PhD, O. Glehen, MD, PhD, and J. M. Bereder, MD
Read AbstractHIPEC in recurrent ovarian cancer patients: Morbidity-related treatment andlong-term analysis of clinical outcome
Anna Fagotti, Barbara Costantini, Giuseppe Vizzielli, Federica Perelli, Alfredo Ercoli,Valerio Gallotta, Giovanni Scambia, Francesco Fanfani
Read AbstractCytoreductive surgery and hyperthermic intraperitoneal chemotherapy as upfront therapy for advanced epithelial ovarian cancer: Multi-institutional phase-II trial
Read Abstract
Cytoreductive Surgery and Hyperthermic Intraperitoneal Chemotherapy for Gastric Cancer with Synchronous Peritoneal Metastases: Multicenter Study of ‘Italian Peritoneal SurfaceMalignancies Oncoteam—S.I.C.O.'
Luigi Marano, MD, PhD, Daniele Marrelli, MD, Paolo Sammartino, MD, PhD, Daniele Biacchi, MD, PhD,Luigina Graziosi, MD, PhD, Elisabetta Marino, MD, Federico Coccolini, MD, Paola Fugazzola, MD, Mario Valle, MD, Orietta Federici, MD, Dario Baratti, MD, Marcello Deraco, MD, Andrea Di Giorgio, MD, Antonio Macrì, MD, Enrico Maria Pasqual, MD, Massimo Framarini, MD, PhD, Marco Vaira, MD, Franco Roviello, MD
Read AbstractA Phase II Trial of Cytoreduction, Gastrectomy, and Hyperthermic Intraperitoneal Perfusion with Chemotherapy for Patients with Gastric Cancer and Carcinomatosis or Positive Cytology
Brian Badgwell, MD, MS, Naruhiko Ikoma, MD, MS, Mariela Blum Murphy, MD, Xuemei Wang, MS,Jeannelyn Estrella, MD, Sinchita Roy-Chowdhuri, MD, PhD, Prajnan Das, MD, Bruce D. Minsky, MD,Elizabeth Lano, MD, Shumei Song, PhD, Paul Mansfield, MD, and Jaffer Ajani, MD
Read AbstractProphylactic HIPEC with radical D2 gastrectomy improves survival and peritoneal recurrence rates for locally advanced gastric cancer: personal experience from a randomized case control study
Maneesh Kumarsing Beeharry, Zheng-Lun Zhu, Wen-Tao Liu, Xue-Xin Yao*, Min Yan and Zheng-Gang Zhu
Read AbstractEffect of hyperthermic intraperitoneal chemotherapy for gastric cancer patients: a meta-analysis of therandomized controlled trials
Yan-Wen Liu, Ying Du and Bao-An Chen
Read AbstractCytoreductive Surgery With or Without Hyperthermic Intraperitoneal Chemotherapy for Gastric Cancer With Peritoneal Metastases (CYTO-CHIP study): A Propensity Score Analysis
Pierre-Emmanuel Bonnot, MD; Guillaume Piessen, MD, PhD; Vahan Kepenekian, MD; Evelyne Decullier, PhD;Marc Pocard, MD, PhD; Bernard Meunier, PhD; Jean-Marc Bereder, MD; Karine Abboud, MD; Frederic Marchal, MD, PhD;François Quenet, MD; Diane Goere, MD, PhD; Simon Msika, MD, PhD; Catherine Arvieux, MD, PhD; Nicolas Pirro, MD, PhD;Romuald Wernert, MD; Patrick Rat, MD, PhD; Johan Gagniere, MD, PhD; Jeremie H. Lefevre, MD, PhD; Thomas Courvoisier, MD;Reza Kianmanesh, MD, PhD; Delphine Vaudoyer, MD; Michel Rivoire, MD, PhD; Pierre Meeus, MD;Guillaume Passot, MD, PhD and Olivier Glehen, MD, PhD
Read AbstractCytoreductive Surgery and Hyperthermic Intraperitoneal Chemotherapy (HIPEC) for Gastric Cancer with Peritoneal Carcinomatosis: Multicenter Study of Spanish Group of Peritoneal Oncologic Surgery (GECOP)
Israel Manzanedo, MD, Fernando Pereira, MD, PhD, Cristina Rihuete Caro, MD, Estibalitz Perez-Viejo, MD, PhD, Angel Serrano, MD, PhD, Alberto Gutierrez Calvo, MD, Fernando M. Regueira, MD, Angela Casado-Adam, MD, Pedro A. Cascales-Campos, MD, PhD, Xabier Arteaga, MD, Alfonso Garcia-Fadrique, MD, Remedios Gomez Sanz, MD, Adela Lopez Garcia, MD, Gabriel Zozaya, MD,Alvaro Arjona, MD, and Jose Gil Martinez, MD
Read AbstractCytoreductive surgery and Hyperthermic intra-operative peritoneal chemotherapy with Cisplatin for gastric peritoneal Carcinomatosis Monocentric phase-2 nonrandomized prospective clinical trial
Baki Topal, Karel Demey, Halit Topal, Joris Jaekers, Eric Van Cutsem, Vincent Vandecaveye, Xavier Sagaert and Hans Prenen
Read AbstractIntraoperative hyperthermic intraperitoneal chemotherapy as adjuvantchemotherapy for advanced gastric cancer patients with serosal invasion
Lung-Yun Kang, King-Tong Mok, Shiuh-Inn Liu, Cheng-Chong Tsai, Being-Whey Wang,I-Shu Chen, Yu-Chia Chen, Bo-Min Chang, Nan-Hua Chou
Read AbstractCytoreductive Surgery and Hyperthermic Intraperitoneal Chemotherapy Improves Survival of Patients with Peritoneal Carcinomatosis from Gastric Cancer: Final Results of a Phase III Randomized Clinical Trial
Xiao-Jun Yang, MD, Chao-Qun Huang, MD, Tao Suo, MD, Lie-Jun Mei, MD, Guo-Liang Yang, MD,Fu-Lin Cheng, MD, Yun-Feng Zhou, MD, PhD, Bin Xiong, MD, PhD, Yutaka Yonemura, MD, PhD,and Yan Li, MD, PhD
Read AbstractPeritoneal Carcinomatosis from Gastric Cancer: A Multi-Institutional Study of 159 Patients Treated by Cytoreductive Surgery Combined with Perioperative Intraperitoneal Chemotherapy
Olivier Glehen, MD, PhD, Franc ̧ois Noel Gilly, MD, PhD, Catherine Arvieux, MD, PhD, Eddy Cotte, MD,Florent Boutitie, Baudouin Mansvelt, MD, PhD, Jean Marc Bereder, MD, Gerard Lorimier, MD, Francois Quenet, MD, Dominique Elias, MD, PhD
Read AbstractThe Current Practice of Cytoreductive Surgery and HIPEC for Colorectal Peritoneal Metastases: Results of a worldwide web-based survey of the Peritoneal Surface Oncology Group International (PSOGI)
Bushati M, MD; Rovers KP, MD; Sommariva A, MD; Sugarbaker PH, MD; Morris DL, MD, PhD; Yonemura Y, MD, PhD; Quadros CA, MD, PhD; Somashekhar SP, MD, PhD; Ceelen W, MD, PhD; Dubé P, MD; LI Y, MD, PhD; Verwaal VJ, MD, PhD; Glehen O, MD, PhD; Piso P, MD, PhD; Spiliotis J, MD, PhD; Teo MCC, MD, PhD; González-Moreno S, MD, PhD; Cashin PH, MD, PhD; Lehmann K, MD, PhD; Deraco M, MD; Moran B, MD, PhD; de Hingh IHJT, MD, PhD
Read AbstractPerioperative systemic chemotherapy, cytoreductive surgery (CRS) and hyperthermic intraperitoneal chemotherapy (HIPEC) in patients with colorectal peritoneal metastasis: results of the prospective multicenter phase II COMBATAC trial
Gabriel Glockzin, Florian Zeman, Roland S. Croner, Alfred Königsrainer, Jörg Pelz, Michael A. Ströhlein, Beate Rau, Dirk Arnold, Michael Koller, Hans J. Schlitt, Pompiliu Piso
Read AbstractBenefit of cytoreductive surgery combined with hyperthermicintraperitoneal chemotherapy in patients with isolated peritoneal metastases from colorectal cancer
mpiliu Piso, Kathrin Stierstorfer, Michael Gerken, Monika Klinkhammer-Schalke
Read AbstractHyperthermic Intraperitoneal Chemotherapy (HIPEC) at the Time of Primary Curative Surgery in Patients with Colorectal Cancer at High Risk for Metachronous Peritoneal Metastases
Read Abstract
Trends in cytoreductive surgery and hyperthermic intraperitoneal chemotherapy for the treatment of synchronous peritoneal carcinomatosis of colorectal origin in the Netherlands
L.G.E.M. Razenberga,b, Y.R.B.M. van Gestelb, G.-J. Creemersa,V.J. Verwaalc, V.E.P.P. Lemmensb,d, I.H.J.T. de Hing
Read AbstractThe American Society of Peritoneal Surface Malignancies (ASPSM) Multiinstitution Evaluation of the Peritoneal Surface Disease Severity Score (PSDSS) in 1,013 Patients with ColorectalCancer with Peritoneal Carcinomatosis
Jesus Esquivel, MD, Andrew M. Lowy, MD, Maurie Markman, MD, Terence Chua, MD, Joerg Pelz, MD, Dario Baratti, MD, Joel M. Baumgartner, MD, Richard Berri, MD, Pedro Bretcha-Boix, MD, Marcello Deraco,MD, Guillermo Flores-Ayala, MD, Olivier Glehen, MD, Alberto Gomez-Portilla, MD, Santiago Gonzalez-Moreno, MD, Martin Goodman, MD, Evgenia Halkia, MD, Shigeki Kusamura, MD, Mecker Moller, MD,Guillaume Passot, MD, Marc Pocard, MD, George Salti, MD, Armando Sardi, MD, Maheswari Senthil,MD, John Spilioitis, MD, Juan Torres-Melero, MD, Kiran Turaga, MD, and Richard Trout, PhD
Read AbstractConsensus Guidelines from The American Society of Peritoneal Surface Malignancies on Standardizing the Delivery of Hyperthermic Intraperitoneal Chemotherapy (HIPEC)in Colorectal Cancer Patients in the United States
K. Turaga, E. Levine, R. Barone, R. Sticca, N. Petrelli, L. Lambert, G. Nash, M. Morse, R. Adbel-Misih, H. R. Alexander, F. Attiyeh, D. Bartlett, A. Bastidas, T. Blazer, Q. Chu, K. Chung, L. Dominguez-Parra, N. J. Espat, J. Foster, K. Fournier, R. Garcia, M. Goodman, N. Hanna, L. Harrison, R. Hoefer, M. Holtzman, J. Kane, D. Labow, B.Li, A. Lowy, P. Mansfield, E. Ong, C. Pameijer, J. Pingpank, M. Quinones, R. Royal, G. Salti, A. Sardi, P. Shen, J. Skitzki, J. Spellman, J. Stewart, and J. Esquivel
Read AbstractResults of Systematic Second-look Surgery Plus HIPEC in Asymptomatic Patients Presenting a High Risk of Developing Colorectal Peritoneal Carcinomatosis
D Elias, MD, PhD, C Honore, MD, F Dumont, MD,M. Ducreux, MD, PhD, V. Boige, MD, PhD, D. Malka, MD, PhD, P. Burtin, MD, C. Dromain, MD, and D. Goere, MD
Read AbstractComplete cytoreductive surgery plus intraperitoneal chemohyperthermia with oxaliplatin for peritoneal carcinomatosis of colorectal origin
Dominique Elias , Jérémie H. Lefevre , Julie Chevalier , Antoine Brouquet , Frédéric Marchal , Jean-Marc Classe, Gwenaël Ferron , Jean-Marc Guilloit , Pierre Meeus , Diane Goéré , Julia Bonastre
Read AbstractRandomized Trial of Cytoreduction and Hyperthermic Intraperitoneal Chemotherapy Versus Systemic Chemotherapy and Palliative Surgery in Patients With Peritoneal Carcinomatosis of Colorectal Cancer
Vic J. Verwaal, Serge van Ruth, Eelco de Bree, Gooike W. van Slooten, Harm van Tinteren, Henk Boot and Frans A.N. Zoetmulder
Read AbstractWell differentiated papillary peritoneal mesothelioma treated by cytoreduction andhyperthermic intraperitoneal chemotherapy - the experience of the PSOGI registry
Marcello Deraco, Eran Nizri, Olivier Glehen, Dario Baratti, Jean-Jacques Tuech,Jean-Marc Bereder, Vahan Kepenekian, Shigeki Kusamura, Diane Goere
Read AbstractMulticystic mesothelioma: operative and long-term outcomes with cytoreductive surgery and hyperthermic intra peritoneal chemotherapy
Eran Nizri, Dario Baratti, Marcello Guaglio, Snita Sinukumar, Antonello Cabras,Shigeki Kusamura, Marcello Deraco
Read AbstractTreatment factors associated with long-term survival after cytoreductive surgery and regional chemotherapy for patients with malignant peritoneal mesothelioma
H. Richard Alexander, Jr, MD, David L. Bartlett, MD, James F. Pingpank, MD, Steven K. Libutti, MD, Richard Royal, MD, Marybeth S. Hughes, MD, Matthew Holtzman, MD, Nader Hanna, MD, Keli Turner, MD, Tatiana Beresneva, MD, and Yue Zhu, MD, MS
Read AbstractCytoreductive Surgery with Selective Versus Complete Parietal Peritonectomy Followed by Hyperthermic Intraperitoneal Chemotherapy in Patients with Diffuse Malignant Peritoneal Mesothelioma: A Controlled Study
Dario Baratti, MD, Shigeki Kusamura, PhD, Antonello Domenico Cabras, MD, and Marcello Deraco, MD
Read AbstractCytoreductive Surgery with Hyperthermic Intraperitoneal Chemotherapy for Malignant Peritoneal Mesothelioma
Aaron U. Blackham, M.D. and Edward A. Levine, M.D.
Read AbstractCytoreductive Surgery and Hyperthermic IntraperitonealChemotherapy for Malignant Peritoneal Mesothelioma: Multi-Institutional Experience
Tristan D. Yan, Marcello Deraco, Dario Baratti, Shigeki Kusamura, Dominique Elias, Olivier Glehen, Francois N. Gilly, Edward A. Levine, Perry Shen, Faheez Mohamed, Brendan J. Moran, David L. Morris,Terence C. Chua, Pompiliu Piso, and Paul H. Sugarbaker
Read AbstractConsensus Statement on Peritoneal Mesothelioma
MARCELLO DERACO,MD, DAVID BARTLETT, SHIGEKI KUSAMURA,MD, AND DARIO BARATTI,MD
Read AbstractCytoreductive Surgery With or Without HIPEC After Neoadjuvant Chemotherapy in Ovarian Cancer: A Phase 3 Clinical Trial
Cascales Campos Pedro Antonio, MD, PHD, Gonzalez Gil Alida, MD, PHD, Gil Gomez Elena, MD, PH1,Gonzalez Sanchez Rocio, PHD, Martınez Garcia Jeronimo, MD, PHD, Alonso Romero Jose Luis, MD, PHD, Nieto Diaz Anibal, MD, PHD, Barcelo Valcarcel Francisco, MD, PHD, Gomez Ruiz Alvaro Jesus, MD, PHD,Ramirez Romero Pablo, MD, PHD, and Gil Martinez Jose, MD, PHD
Read AbstractEvaluation of Cytoreductive Surgery With or Without Hyperthermic Intraperitoneal Chemotherapy for Stage III Epithelial Ovarian Cancer
Ziying Lei, MD; Yue Wang, MD; Jiahong Wang, MD; Ke Wang, MD; Jun Tian, MD; Ying Zhao, MD; Lipai Chen, MD; Jin Wang, MD; Jiali Luo, PhD; Manman Jia, MD;Hongsheng Tang, MD; Qingjun He, MD; Quanxing Liao, MD; Xiansheng Yang, MD; Tianpei Guan, MD; Li Wang, MD; Shuzhong Cui, MD, PhD;
Read AbstractThe prognosis impact of hyperthermic intraperitoneal chemotherapy (HIPEC) plus cytoreductive surgery (CRS) in advanced ovarian cancer: the meta-analysis
Guyu Zhang, Yimin Zhu, Chongdong Liu, Guangming Chao, Ran Cui and Zhenyu Zhang
Read AbstractSelection of patients with ovarian cancer who may show survival benefit from hyperthermic intraperitoneal chemotherapy: a systematic review and meta-analysis
Se Ik Kim, MD, Jaehyun Cho, MD, Eun Ji Lee, MD, Sunwoo Park, BS, Soo Jin Park, MDa,Aeran Seol, MD, Nara Lee, MD, Ga Won Yim, MD, PhD, Maria Lee, MD, PhD, Whasun Lim, PhD,Gwonhwa Song, PhD, Suk Joon Chang, MD, PhD, Jae Won Kim, MD, PhD, Hee Seung Kim, MD, PhD
Read AbstractCost-effectiveness of hyperthermic intraperitoneal chemotherapy (HIPEC) at interval debulking of epithelial ovarian cancer following neoadjuvant chemotherapy
Stephanie L.Lima, Laura J.Havrilesky, Ashraf S.Habib, Angeles Alvarez Secord
Read AbstractCost Effectiveness of Interval Cytoreductive Surgery With Hyperthermic Intraperitoneal Chemotherapy in Stage III Ovarian Cancer on the Basis of a Randomized Phase III Trial
Simone N. Koole, MD; Christiaan van Lieshout, MSc; Willemien J. van Driel, PhD, MD; Evi van Schagen, MSc;Karolina Sikorska, PhD; Jacobien M. Kieffer, PhD; Jules H. Schagen van Leeuwen, MD, PhD; Henk W.R. Schreuder, MD, PhD;Ralph H. Hermans, MD, PhD; Ignace H. de Hingh, MD, PhD; Jacobus van der Velden, PhD, MD; Henriette J. Arts, MD, PhD;Leon F.A.G. Massuger, MD, PhD; Arend G. Aalbers, MD; Victor J. Verwaal, MD, PhD; Koen K. Van de Vijver, MD, PhD;Neil K. Aaronson, PhD; Harm van Tinteren, PhD; Gabe S. Sonke, MD, PhD; Wim H. van Harten, MD, PhD;andValesca P. Ret`el, PhD
Read AbstractHyperthermic Intraperitoneal Chemotherapy in Ovarian Cancer
W.J. van Driel, S.N. Koole, K. Sikorska, J.H. Schagen van Leeuwen, H.W.R. Schreuder, R.H.M. Hermans, I.H.J.T. de Hingh, J. van der Velden, H.J. Arts, L.F.A.G. Massuger, A.G.J. Aalbers, V.J. Verwaal, J.M. Kieffer, K.K. Van de Vijver, H. van Tinteren, N.K. Aaronson, and G.S. Sonke
Read AbstractCytoreductive Surgery and HIPEC in Recurrent Epithelial Ovarian Cancer: A Prospective Randomized Phase III Study
J. Spiliotis, MD, PhD, E. Halkia, MD, PhD, E. Lianos, MD, N. Kalantzi, MD, A. Grivas, MD, E. Efstathiou, MD, and S. Giassas, MD
Read AbstractIntraperitoneal chemotherapy in ovarian cancer: a review of tolerance and efficacy
Daniel L Chan, David L Morris, Archana Rao, Terence C Chua
Read AbstractCytoreductive Surgery and Hyperthermic Intraperitoneal Chemotherapy (HIPEC) for Persistent and Recurrent Advanced Ovarian Carcinoma: A Multicenter, Prospective Study of 246 Patients
N. Bakrin, MD, E. Cotte, MD, F. Golfier MD, PhD, F. N. Gilly, MD, PhD, G. Freyer, MD, PhD, W. Helm, MD,PhD, O. Glehen, MD, PhD, and J. M. Bereder, MD
Read AbstractHIPEC in recurrent ovarian cancer patients: Morbidity-related treatment andlong-term analysis of clinical outcome
Anna Fagotti, Barbara Costantini, Giuseppe Vizzielli, Federica Perelli, Alfredo Ercoli,Valerio Gallotta, Giovanni Scambia, Francesco Fanfani
Read AbstractCytoreductive surgery and hyperthermic intraperitoneal chemotherapy as upfront therapy for advanced epithelial ovarian cancer: Multi-institutional phase-II trial
Read Abstract
Desmoplastic Small Round Cell Tumor Treated with Cytoreductive Surgery and Hyperthermic Intraperitoneal Chemotherapy: Results of a Phase 2 Trial
Andrea A. Hayes-Jordan, MD, Brian A. Coakley, MD, Holly L. Green, PA-C, LianChun Xiao, MS, Keith F. Fournier, MD, Cynthia E. Herzog, MD, Joseph A. Ludwig, MD, Mary F. McAleer, MD PhD, Peter M. Anderson, MD PhD, and Winston W. Huh, MD
Read AbstractCytoreductive surgery and hyperthermic intraperitoneal chemotherapy: A safe treatment option for intraperitoneal rhabdomyosarcoma in children below 5 years of age
Jens Gesche, Stefan Beckert, Felix Neunhoeffer, Denis Kachanov, Alfred Königsrainer, Guido Seitz, Jörg Fuchs
Read AbstractCytoreductive surgery and hyperthermic intraperitoneal perfusion with chemotherapy in children with peritoneal tumor spread: A French nation wide study over 14 years
Read Abstract
Cytoreductive Surgery With or Without HIPEC After Neoadjuvant Chemotherapy in Ovarian Cancer: A Phase 3 Clinical Trial
Cascales Campos Pedro Antonio, MD, PHD, Gonzalez Gil Alida, MD, PHD, Gil Gomez Elena, MD, PH1,Gonzalez Sanchez Rocio, PHD, Martınez Garcia Jeronimo, MD, PHD, Alonso Romero Jose Luis, MD, PHD, Nieto Diaz Anibal, MD, PHD, Barcelo Valcarcel Francisco, MD, PHD, Gomez Ruiz Alvaro Jesus, MD, PHD,Ramirez Romero Pablo, MD, PHD, and Gil Martinez Jose, MD, PHD
Read AbstractEvaluation of Cytoreductive Surgery With or Without Hyperthermic Intraperitoneal Chemotherapy for Stage III Epithelial Ovarian Cancer
Ziying Lei, MD; Yue Wang, MD; Jiahong Wang, MD; Ke Wang, MD; Jun Tian, MD; Ying Zhao, MD; Lipai Chen, MD; Jin Wang, MD; Jiali Luo, PhD; Manman Jia, MD;Hongsheng Tang, MD; Qingjun He, MD; Quanxing Liao, MD; Xiansheng Yang, MD; Tianpei Guan, MD; Li Wang, MD; Shuzhong Cui, MD, PhD;
Read AbstractThe prognosis impact of hyperthermic intraperitoneal chemotherapy (HIPEC) plus cytoreductive surgery (CRS) in advanced ovarian cancer: the meta-analysis
Guyu Zhang, Yimin Zhu, Chongdong Liu, Guangming Chao, Ran Cui and Zhenyu Zhang
Read AbstractSelection of patients with ovarian cancer who may show survival benefit from hyperthermic intraperitoneal chemotherapy: a systematic review and meta-analysis
Se Ik Kim, MD, Jaehyun Cho, MD, Eun Ji Lee, MD, Sunwoo Park, BS, Soo Jin Park, MDa,Aeran Seol, MD, Nara Lee, MD, Ga Won Yim, MD, PhD, Maria Lee, MD, PhD, Whasun Lim, PhD,Gwonhwa Song, PhD, Suk Joon Chang, MD, PhD, Jae Won Kim, MD, PhD, Hee Seung Kim, MD, PhD
Read AbstractCost-effectiveness of hyperthermic intraperitoneal chemotherapy (HIPEC) at interval debulking of epithelial ovarian cancer following neoadjuvant chemotherapy
Stephanie L.Lima, Laura J.Havrilesky, Ashraf S.Habib, Angeles Alvarez Secord
Read AbstractCost Effectiveness of Interval Cytoreductive Surgery With Hyperthermic Intraperitoneal Chemotherapy in Stage III Ovarian Cancer on the Basis of a Randomized Phase III Trial
Simone N. Koole, MD; Christiaan van Lieshout, MSc; Willemien J. van Driel, PhD, MD; Evi van Schagen, MSc;Karolina Sikorska, PhD; Jacobien M. Kieffer, PhD; Jules H. Schagen van Leeuwen, MD, PhD; Henk W.R. Schreuder, MD, PhD;Ralph H. Hermans, MD, PhD; Ignace H. de Hingh, MD, PhD; Jacobus van der Velden, PhD, MD; Henriette J. Arts, MD, PhD;Leon F.A.G. Massuger, MD, PhD; Arend G. Aalbers, MD; Victor J. Verwaal, MD, PhD; Koen K. Van de Vijver, MD, PhD;Neil K. Aaronson, PhD; Harm van Tinteren, PhD; Gabe S. Sonke, MD, PhD; Wim H. van Harten, MD, PhD;andValesca P. Ret`el, PhD
Read AbstractHyperthermic Intraperitoneal Chemotherapy in Ovarian Cancer
W.J. van Driel, S.N. Koole, K. Sikorska, J.H. Schagen van Leeuwen, H.W.R. Schreuder, R.H.M. Hermans, I.H.J.T. de Hingh, J. van der Velden, H.J. Arts, L.F.A.G. Massuger, A.G.J. Aalbers, V.J. Verwaal, J.M. Kieffer, K.K. Van de Vijver, H. van Tinteren, N.K. Aaronson, and G.S. Sonke
Read AbstractCytoreductive Surgery and HIPEC in Recurrent Epithelial Ovarian Cancer: A Prospective Randomized Phase III Study
J. Spiliotis, MD, PhD, E. Halkia, MD, PhD, E. Lianos, MD, N. Kalantzi, MD, A. Grivas, MD, E. Efstathiou, MD, and S. Giassas, MD
Read AbstractIntraperitoneal chemotherapy in ovarian cancer: a review of tolerance and efficacy
Daniel L Chan, David L Morris, Archana Rao, Terence C Chua
Read AbstractCytoreductive Surgery and Hyperthermic Intraperitoneal Chemotherapy (HIPEC) for Persistent and Recurrent Advanced Ovarian Carcinoma: A Multicenter, Prospective Study of 246 Patients
N. Bakrin, MD, E. Cotte, MD, F. Golfier MD, PhD, F. N. Gilly, MD, PhD, G. Freyer, MD, PhD, W. Helm, MD,PhD, O. Glehen, MD, PhD, and J. M. Bereder, MD
Read AbstractHIPEC in recurrent ovarian cancer patients: Morbidity-related treatment andlong-term analysis of clinical outcome
Anna Fagotti, Barbara Costantini, Giuseppe Vizzielli, Federica Perelli, Alfredo Ercoli,Valerio Gallotta, Giovanni Scambia, Francesco Fanfani
Read AbstractCytoreductive surgery and hyperthermic intraperitoneal chemotherapy as upfront therapy for advanced epithelial ovarian cancer: Multi-institutional phase-II trial
Read Abstract
Cytoreductive Surgery and Hyperthermic Intraperitoneal Chemotherapy for Gastric Cancer with Synchronous Peritoneal Metastases: Multicenter Study of ‘Italian Peritoneal SurfaceMalignancies Oncoteam—S.I.C.O.'
Luigi Marano, MD, PhD, Daniele Marrelli, MD, Paolo Sammartino, MD, PhD, Daniele Biacchi, MD, PhD,Luigina Graziosi, MD, PhD, Elisabetta Marino, MD, Federico Coccolini, MD, Paola Fugazzola, MD, Mario Valle, MD, Orietta Federici, MD, Dario Baratti, MD, Marcello Deraco, MD, Andrea Di Giorgio, MD, Antonio Macrì, MD, Enrico Maria Pasqual, MD, Massimo Framarini, MD, PhD, Marco Vaira, MD, Franco Roviello, MD
Read AbstractA Phase II Trial of Cytoreduction, Gastrectomy, and Hyperthermic Intraperitoneal Perfusion with Chemotherapy for Patients with Gastric Cancer and Carcinomatosis or Positive Cytology
Brian Badgwell, MD, MS, Naruhiko Ikoma, MD, MS, Mariela Blum Murphy, MD, Xuemei Wang, MS,Jeannelyn Estrella, MD, Sinchita Roy-Chowdhuri, MD, PhD, Prajnan Das, MD, Bruce D. Minsky, MD,Elizabeth Lano, MD, Shumei Song, PhD, Paul Mansfield, MD, and Jaffer Ajani, MD
Read AbstractProphylactic HIPEC with radical D2 gastrectomy improves survival and peritoneal recurrence rates for locally advanced gastric cancer: personal experience from a randomized case control study
Maneesh Kumarsing Beeharry, Zheng-Lun Zhu, Wen-Tao Liu, Xue-Xin Yao*, Min Yan and Zheng-Gang Zhu
Read AbstractEffect of hyperthermic intraperitoneal chemotherapy for gastric cancer patients: a meta-analysis of therandomized controlled trials
Yan-Wen Liu, Ying Du and Bao-An Chen
Read AbstractCytoreductive Surgery With or Without Hyperthermic Intraperitoneal Chemotherapy for Gastric Cancer With Peritoneal Metastases (CYTO-CHIP study): A Propensity Score Analysis
Pierre-Emmanuel Bonnot, MD; Guillaume Piessen, MD, PhD; Vahan Kepenekian, MD; Evelyne Decullier, PhD;Marc Pocard, MD, PhD; Bernard Meunier, PhD; Jean-Marc Bereder, MD; Karine Abboud, MD; Frederic Marchal, MD, PhD;François Quenet, MD; Diane Goere, MD, PhD; Simon Msika, MD, PhD; Catherine Arvieux, MD, PhD; Nicolas Pirro, MD, PhD;Romuald Wernert, MD; Patrick Rat, MD, PhD; Johan Gagniere, MD, PhD; Jeremie H. Lefevre, MD, PhD; Thomas Courvoisier, MD;Reza Kianmanesh, MD, PhD; Delphine Vaudoyer, MD; Michel Rivoire, MD, PhD; Pierre Meeus, MD;Guillaume Passot, MD, PhD and Olivier Glehen, MD, PhD
Read AbstractCytoreductive Surgery and Hyperthermic Intraperitoneal Chemotherapy (HIPEC) for Gastric Cancer with Peritoneal Carcinomatosis: Multicenter Study of Spanish Group of Peritoneal Oncologic Surgery (GECOP)
Israel Manzanedo, MD, Fernando Pereira, MD, PhD, Cristina Rihuete Caro, MD, Estibalitz Perez-Viejo, MD, PhD, Angel Serrano, MD, PhD, Alberto Gutierrez Calvo, MD, Fernando M. Regueira, MD, Angela Casado-Adam, MD, Pedro A. Cascales-Campos, MD, PhD, Xabier Arteaga, MD, Alfonso Garcia-Fadrique, MD, Remedios Gomez Sanz, MD, Adela Lopez Garcia, MD, Gabriel Zozaya, MD,Alvaro Arjona, MD, and Jose Gil Martinez, MD
Read AbstractCytoreductive surgery and Hyperthermic intra-operative peritoneal chemotherapy with Cisplatin for gastric peritoneal Carcinomatosis Monocentric phase-2 nonrandomized prospective clinical trial
Baki Topal, Karel Demey, Halit Topal, Joris Jaekers, Eric Van Cutsem, Vincent Vandecaveye, Xavier Sagaert and Hans Prenen
Read AbstractIntraoperative hyperthermic intraperitoneal chemotherapy as adjuvantchemotherapy for advanced gastric cancer patients with serosal invasion
Lung-Yun Kang, King-Tong Mok, Shiuh-Inn Liu, Cheng-Chong Tsai, Being-Whey Wang,I-Shu Chen, Yu-Chia Chen, Bo-Min Chang, Nan-Hua Chou
Read AbstractCytoreductive Surgery and Hyperthermic Intraperitoneal Chemotherapy Improves Survival of Patients with Peritoneal Carcinomatosis from Gastric Cancer: Final Results of a Phase III Randomized Clinical Trial
Xiao-Jun Yang, MD, Chao-Qun Huang, MD, Tao Suo, MD, Lie-Jun Mei, MD, Guo-Liang Yang, MD,Fu-Lin Cheng, MD, Yun-Feng Zhou, MD, PhD, Bin Xiong, MD, PhD, Yutaka Yonemura, MD, PhD,and Yan Li, MD, PhD
Read AbstractPeritoneal Carcinomatosis from Gastric Cancer: A Multi-Institutional Study of 159 Patients Treated by Cytoreductive Surgery Combined with Perioperative Intraperitoneal Chemotherapy
Olivier Glehen, MD, PhD, Franc ̧ois Noel Gilly, MD, PhD, Catherine Arvieux, MD, PhD, Eddy Cotte, MD,Florent Boutitie, Baudouin Mansvelt, MD, PhD, Jean Marc Bereder, MD, Gerard Lorimier, MD, Francois Quenet, MD, Dominique Elias, MD, PhD
Read AbstractThe Current Practice of Cytoreductive Surgery and HIPEC for Colorectal Peritoneal Metastases: Results of a worldwide web-based survey of the Peritoneal Surface Oncology Group International (PSOGI)
Bushati M, MD; Rovers KP, MD; Sommariva A, MD; Sugarbaker PH, MD; Morris DL, MD, PhD; Yonemura Y, MD, PhD; Quadros CA, MD, PhD; Somashekhar SP, MD, PhD; Ceelen W, MD, PhD; Dubé P, MD; LI Y, MD, PhD; Verwaal VJ, MD, PhD; Glehen O, MD, PhD; Piso P, MD, PhD; Spiliotis J, MD, PhD; Teo MCC, MD, PhD; González-Moreno S, MD, PhD; Cashin PH, MD, PhD; Lehmann K, MD, PhD; Deraco M, MD; Moran B, MD, PhD; de Hingh IHJT, MD, PhD
Read AbstractPerioperative systemic chemotherapy, cytoreductive surgery (CRS) and hyperthermic intraperitoneal chemotherapy (HIPEC) in patients with colorectal peritoneal metastasis: results of the prospective multicenter phase II COMBATAC trial
Gabriel Glockzin, Florian Zeman, Roland S. Croner, Alfred Königsrainer, Jörg Pelz, Michael A. Ströhlein, Beate Rau, Dirk Arnold, Michael Koller, Hans J. Schlitt, Pompiliu Piso
Read AbstractBenefit of cytoreductive surgery combined with hyperthermicintraperitoneal chemotherapy in patients with isolated peritoneal metastases from colorectal cancer
mpiliu Piso, Kathrin Stierstorfer, Michael Gerken, Monika Klinkhammer-Schalke
Read AbstractHyperthermic Intraperitoneal Chemotherapy (HIPEC) at the Time of Primary Curative Surgery in Patients with Colorectal Cancer at High Risk for Metachronous Peritoneal Metastases
Read Abstract
Trends in cytoreductive surgery and hyperthermic intraperitoneal chemotherapy for the treatment of synchronous peritoneal carcinomatosis of colorectal origin in the Netherlands
L.G.E.M. Razenberga,b, Y.R.B.M. van Gestelb, G.-J. Creemersa,V.J. Verwaalc, V.E.P.P. Lemmensb,d, I.H.J.T. de Hing
Read AbstractThe American Society of Peritoneal Surface Malignancies (ASPSM) Multiinstitution Evaluation of the Peritoneal Surface Disease Severity Score (PSDSS) in 1,013 Patients with ColorectalCancer with Peritoneal Carcinomatosis
Jesus Esquivel, MD, Andrew M. Lowy, MD, Maurie Markman, MD, Terence Chua, MD, Joerg Pelz, MD, Dario Baratti, MD, Joel M. Baumgartner, MD, Richard Berri, MD, Pedro Bretcha-Boix, MD, Marcello Deraco,MD, Guillermo Flores-Ayala, MD, Olivier Glehen, MD, Alberto Gomez-Portilla, MD, Santiago Gonzalez-Moreno, MD, Martin Goodman, MD, Evgenia Halkia, MD, Shigeki Kusamura, MD, Mecker Moller, MD,Guillaume Passot, MD, Marc Pocard, MD, George Salti, MD, Armando Sardi, MD, Maheswari Senthil,MD, John Spilioitis, MD, Juan Torres-Melero, MD, Kiran Turaga, MD, and Richard Trout, PhD
Read AbstractConsensus Guidelines from The American Society of Peritoneal Surface Malignancies on Standardizing the Delivery of Hyperthermic Intraperitoneal Chemotherapy (HIPEC)in Colorectal Cancer Patients in the United States
K. Turaga, E. Levine, R. Barone, R. Sticca, N. Petrelli, L. Lambert, G. Nash, M. Morse, R. Adbel-Misih, H. R. Alexander, F. Attiyeh, D. Bartlett, A. Bastidas, T. Blazer, Q. Chu, K. Chung, L. Dominguez-Parra, N. J. Espat, J. Foster, K. Fournier, R. Garcia, M. Goodman, N. Hanna, L. Harrison, R. Hoefer, M. Holtzman, J. Kane, D. Labow, B.Li, A. Lowy, P. Mansfield, E. Ong, C. Pameijer, J. Pingpank, M. Quinones, R. Royal, G. Salti, A. Sardi, P. Shen, J. Skitzki, J. Spellman, J. Stewart, and J. Esquivel
Read AbstractResults of Systematic Second-look Surgery Plus HIPEC in Asymptomatic Patients Presenting a High Risk of Developing Colorectal Peritoneal Carcinomatosis
D Elias, MD, PhD, C Honore, MD, F Dumont, MD,M. Ducreux, MD, PhD, V. Boige, MD, PhD, D. Malka, MD, PhD, P. Burtin, MD, C. Dromain, MD, and D. Goere, MD
Read AbstractComplete cytoreductive surgery plus intraperitoneal chemohyperthermia with oxaliplatin for peritoneal carcinomatosis of colorectal origin
Dominique Elias , Jérémie H. Lefevre , Julie Chevalier , Antoine Brouquet , Frédéric Marchal , Jean-Marc Classe, Gwenaël Ferron , Jean-Marc Guilloit , Pierre Meeus , Diane Goéré , Julia Bonastre
Read AbstractRandomized Trial of Cytoreduction and Hyperthermic Intraperitoneal Chemotherapy Versus Systemic Chemotherapy and Palliative Surgery in Patients With Peritoneal Carcinomatosis of Colorectal Cancer
Vic J. Verwaal, Serge van Ruth, Eelco de Bree, Gooike W. van Slooten, Harm van Tinteren, Henk Boot and Frans A.N. Zoetmulder
Read AbstractWell differentiated papillary peritoneal mesothelioma treated by cytoreduction andhyperthermic intraperitoneal chemotherapy - the experience of the PSOGI registry
Marcello Deraco, Eran Nizri, Olivier Glehen, Dario Baratti, Jean-Jacques Tuech,Jean-Marc Bereder, Vahan Kepenekian, Shigeki Kusamura, Diane Goere
Read AbstractMulticystic mesothelioma: operative and long-term outcomes with cytoreductive surgery and hyperthermic intra peritoneal chemotherapy
Eran Nizri, Dario Baratti, Marcello Guaglio, Snita Sinukumar, Antonello Cabras,Shigeki Kusamura, Marcello Deraco
Read AbstractTreatment factors associated with long-term survival after cytoreductive surgery and regional chemotherapy for patients with malignant peritoneal mesothelioma
H. Richard Alexander, Jr, MD, David L. Bartlett, MD, James F. Pingpank, MD, Steven K. Libutti, MD, Richard Royal, MD, Marybeth S. Hughes, MD, Matthew Holtzman, MD, Nader Hanna, MD, Keli Turner, MD, Tatiana Beresneva, MD, and Yue Zhu, MD, MS
Read AbstractCytoreductive Surgery with Selective Versus Complete Parietal Peritonectomy Followed by Hyperthermic Intraperitoneal Chemotherapy in Patients with Diffuse Malignant Peritoneal Mesothelioma: A Controlled Study
Dario Baratti, MD, Shigeki Kusamura, PhD, Antonello Domenico Cabras, MD, and Marcello Deraco, MD
Read AbstractCytoreductive Surgery with Hyperthermic Intraperitoneal Chemotherapy for Malignant Peritoneal Mesothelioma
Aaron U. Blackham, M.D. and Edward A. Levine, M.D.
Read AbstractCytoreductive Surgery and Hyperthermic IntraperitonealChemotherapy for Malignant Peritoneal Mesothelioma: Multi-Institutional Experience
Tristan D. Yan, Marcello Deraco, Dario Baratti, Shigeki Kusamura, Dominique Elias, Olivier Glehen, Francois N. Gilly, Edward A. Levine, Perry Shen, Faheez Mohamed, Brendan J. Moran, David L. Morris,Terence C. Chua, Pompiliu Piso, and Paul H. Sugarbaker
Read AbstractConsensus Statement on Peritoneal Mesothelioma
MARCELLO DERACO,MD, DAVID BARTLETT, SHIGEKI KUSAMURA,MD, AND DARIO BARATTI,MD
Read AbstractCytoreductive Surgery With or Without HIPEC After Neoadjuvant Chemotherapy in Ovarian Cancer: A Phase 3 Clinical Trial
Cascales Campos Pedro Antonio, MD, PHD, Gonzalez Gil Alida, MD, PHD, Gil Gomez Elena, MD, PH1,Gonzalez Sanchez Rocio, PHD, Martınez Garcia Jeronimo, MD, PHD, Alonso Romero Jose Luis, MD, PHD, Nieto Diaz Anibal, MD, PHD, Barcelo Valcarcel Francisco, MD, PHD, Gomez Ruiz Alvaro Jesus, MD, PHD,Ramirez Romero Pablo, MD, PHD, and Gil Martinez Jose, MD, PHD
Read AbstractEvaluation of Cytoreductive Surgery With or Without Hyperthermic Intraperitoneal Chemotherapy for Stage III Epithelial Ovarian Cancer
Ziying Lei, MD; Yue Wang, MD; Jiahong Wang, MD; Ke Wang, MD; Jun Tian, MD; Ying Zhao, MD; Lipai Chen, MD; Jin Wang, MD; Jiali Luo, PhD; Manman Jia, MD;Hongsheng Tang, MD; Qingjun He, MD; Quanxing Liao, MD; Xiansheng Yang, MD; Tianpei Guan, MD; Li Wang, MD; Shuzhong Cui, MD, PhD;
Read AbstractThe prognosis impact of hyperthermic intraperitoneal chemotherapy (HIPEC) plus cytoreductive surgery (CRS) in advanced ovarian cancer: the meta-analysis
Guyu Zhang, Yimin Zhu, Chongdong Liu, Guangming Chao, Ran Cui and Zhenyu Zhang
Read AbstractSelection of patients with ovarian cancer who may show survival benefit from hyperthermic intraperitoneal chemotherapy: a systematic review and meta-analysis
Se Ik Kim, MD, Jaehyun Cho, MD, Eun Ji Lee, MD, Sunwoo Park, BS, Soo Jin Park, MDa,Aeran Seol, MD, Nara Lee, MD, Ga Won Yim, MD, PhD, Maria Lee, MD, PhD, Whasun Lim, PhD,Gwonhwa Song, PhD, Suk Joon Chang, MD, PhD, Jae Won Kim, MD, PhD, Hee Seung Kim, MD, PhD
Read AbstractCost-effectiveness of hyperthermic intraperitoneal chemotherapy (HIPEC) at interval debulking of epithelial ovarian cancer following neoadjuvant chemotherapy
Stephanie L.Lima, Laura J.Havrilesky, Ashraf S.Habib, Angeles Alvarez Secord
Read AbstractCost Effectiveness of Interval Cytoreductive Surgery With Hyperthermic Intraperitoneal Chemotherapy in Stage III Ovarian Cancer on the Basis of a Randomized Phase III Trial
Simone N. Koole, MD; Christiaan van Lieshout, MSc; Willemien J. van Driel, PhD, MD; Evi van Schagen, MSc;Karolina Sikorska, PhD; Jacobien M. Kieffer, PhD; Jules H. Schagen van Leeuwen, MD, PhD; Henk W.R. Schreuder, MD, PhD;Ralph H. Hermans, MD, PhD; Ignace H. de Hingh, MD, PhD; Jacobus van der Velden, PhD, MD; Henriette J. Arts, MD, PhD;Leon F.A.G. Massuger, MD, PhD; Arend G. Aalbers, MD; Victor J. Verwaal, MD, PhD; Koen K. Van de Vijver, MD, PhD;Neil K. Aaronson, PhD; Harm van Tinteren, PhD; Gabe S. Sonke, MD, PhD; Wim H. van Harten, MD, PhD;andValesca P. Ret`el, PhD
Read AbstractHyperthermic Intraperitoneal Chemotherapy in Ovarian Cancer
W.J. van Driel, S.N. Koole, K. Sikorska, J.H. Schagen van Leeuwen, H.W.R. Schreuder, R.H.M. Hermans, I.H.J.T. de Hingh, J. van der Velden, H.J. Arts, L.F.A.G. Massuger, A.G.J. Aalbers, V.J. Verwaal, J.M. Kieffer, K.K. Van de Vijver, H. van Tinteren, N.K. Aaronson, and G.S. Sonke
Read AbstractCytoreductive Surgery and HIPEC in Recurrent Epithelial Ovarian Cancer: A Prospective Randomized Phase III Study
J. Spiliotis, MD, PhD, E. Halkia, MD, PhD, E. Lianos, MD, N. Kalantzi, MD, A. Grivas, MD, E. Efstathiou, MD, and S. Giassas, MD
Read AbstractIntraperitoneal chemotherapy in ovarian cancer: a review of tolerance and efficacy
Daniel L Chan, David L Morris, Archana Rao, Terence C Chua
Read AbstractCytoreductive Surgery and Hyperthermic Intraperitoneal Chemotherapy (HIPEC) for Persistent and Recurrent Advanced Ovarian Carcinoma: A Multicenter, Prospective Study of 246 Patients
N. Bakrin, MD, E. Cotte, MD, F. Golfier MD, PhD, F. N. Gilly, MD, PhD, G. Freyer, MD, PhD, W. Helm, MD,PhD, O. Glehen, MD, PhD, and J. M. Bereder, MD
Read AbstractHIPEC in recurrent ovarian cancer patients: Morbidity-related treatment andlong-term analysis of clinical outcome
Anna Fagotti, Barbara Costantini, Giuseppe Vizzielli, Federica Perelli, Alfredo Ercoli,Valerio Gallotta, Giovanni Scambia, Francesco Fanfani
Read AbstractCytoreductive surgery and hyperthermic intraperitoneal chemotherapy as upfront therapy for advanced epithelial ovarian cancer: Multi-institutional phase-II trial
Read Abstract
Desmoplastic Small Round Cell Tumor Treated with Cytoreductive Surgery and Hyperthermic Intraperitoneal Chemotherapy: Results of a Phase 2 Trial
Andrea A. Hayes-Jordan, MD, Brian A. Coakley, MD, Holly L. Green, PA-C, LianChun Xiao, MS, Keith F. Fournier, MD, Cynthia E. Herzog, MD, Joseph A. Ludwig, MD, Mary F. McAleer, MD PhD, Peter M. Anderson, MD PhD, and Winston W. Huh, MD
Read AbstractCytoreductive surgery and hyperthermic intraperitoneal chemotherapy: A safe treatment option for intraperitoneal rhabdomyosarcoma in children below 5 years of age
Jens Gesche, Stefan Beckert, Felix Neunhoeffer, Denis Kachanov, Alfred Königsrainer, Guido Seitz, Jörg Fuchs
Read AbstractCytoreductive surgery and hyperthermic intraperitoneal perfusion with chemotherapy in children with peritoneal tumor spread: A French nation wide study over 14 years
Read Abstract